GoodTaste
Key Member
- Joined
- Feb 19, 2016
- Member Type
- Student or Learner
- Native Language
- Chinese
- Home Country
- China
- Current Location
- China
Each of the treatments, Pfizer’s combination of a new antiviral, nirmatrelvir, with an old one, and Merck’s molnupiravir, require 5 days of pills, which the U.S. government has purchased for $530 and $712 per treatment course, respectively. That’s far too expensive for much of the world, but both companies joined the Medicines Patent Pool (MPP) for their patented treatments. A nonprofit set up in 2010, MPP encourages Big Pharmas to voluntarily cut deals that allow generic manufacturers to produce and sell a company’s drugs or vaccines at steep discounts in agreed on regions of the world. “Everyone at the time said this will never happen, this is a crazy idea,” says attorney Ellen ’t Hoen, who helped establish MPP and remains on its expert advisory group.
Source: Science
Do you that the "that" should have been "to" (or use a new structure like "so that generic manufacturers will be allowed to produce..."?
Source: Science
Once a ‘crazy idea,’ patent-pooling nonprofit will help bring COVID-19 pills to world’s poor
It seems to me that the "that" here should have been "to". Because the logic is that Big Pharmas voluntarily cut deals so that generic manufacturers can produce and sell a company’s drugs or vaccines at steep discounts in agreed on regions of the world; that structure of "cut deals that allow generic manufacturers to produce and sell..." is exactly the opposite of this. I am absolutely sure.Do you that the "that" should have been "to" (or use a new structure like "so that generic manufacturers will be allowed to produce..."?
